hotspot -WSS

hotspot

author：comprehensive 2025-08-11 08:00:59 - browse：91

Each COVID-19 vaccine vial from various companies is placed on individual rectangular backgrounds. Pfizer-BioNTech is positioned in the middle on a purple block adorned with two glitter star stickers, Moderna is on the top right on a red block, Janssen is on the bottom right on a blue block, and AstraZeneca is on the left on a red block. — Illustration: Christine Kao/STAT; Photos: Getty

It’s been four years since Covid-19 emerged, igniting a pandemic that killed millions of people and brought the world to its knees. A key factor in taming the pandemic was the creation of effective vaccines, which have saved millions of lives.

You’d think developing a successful vaccine would be an unmitigated win, from a financial perspective. And, indeed, for Pfizer and its partner BioNTech, as well as for Moderna — whose vaccines were the most widely used in the United States and much of the world — the revenues generated were absolutely staggering. But investors have shrugged at those sales as gains that will not be repeated.

Total sales of the Pfizer/BioNTech vaccine surpassed $80 billion, and more than 400 million doses of the shot and subsequent boosters have been administered in the U.S. alone. But the company’s stock price fell 32% over the past five years. Meanwhile, AstraZeneca, which told STAT it has not booked sales from its vaccine since last April and does not expect future sales, has seen its share price rise 64%. Merck, which saw its vaccine efforts fail twice, is up 56%.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： How to save PrEP access — and even expand it
Next article： Novo Nordisk to expand supply of Wegovy for U.S. patients

Wikipedia

WSS

Cybersecurity threat forces Lurie Children's to take systems offline

Some dementia cases could be undiagnosed liver disease

Juul spent big to court Black leaders to promote its e

What is the Turing Test that determines if computers can think?

Family of Gilgo Beach murder suspect releases statement: 'Devastating time'

Prosecutors say FTX founder Sam Bankman

leisure time

hotspot

focus

Medicare details structure of new drug price negotiation program

Why the advice to take all your antibiotics may be wrong

The high cost of giving birth even with insurance

What we need to know about Arena Bioworks

Hepatitis C has a cure — but many Americans still lack access to it

Biden, Billy Joel, Elton John lead tributes for Tony Bennett after singer's death at 96

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

The biotech scorecard for the 2nd quarter: 12 industry events to watch

Malaria cases in Florida and Texas: Here’s what you need to know

In a test for AI, buzzy startup Insitro inks drug discovery deal with Gilead

Wikipedia

Study: Misdiagnosis causes 800,000 deaths, serious disabilities a year in U.S.

'The View' co

Cognito secures funding to test medical device for Alzheimer's

Hey, doctors: Don't be no

Vertex non

Medicare drug price negotiation’s day in court

explore

Wikipedia

entertainment

focus